Recurrent genomic alterations characterize medulloblastoma arising from DNA double-strand break repair deficiency

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• DNA double-strand break repair (DSBR) pathways, including homologous recombination (HR) and nonhomologous end-joining (NHEJ), are crucial for maintaining genomic stability.
• Defects in DSBR can predispose cells to tumorigenesis, but the specific roles of key repair proteins in neural development and medulloblastoma formation require further elucidation.

Purpose of the Study:

• To investigate the role of specific DNA double-strand break repair (DSBR) proteins (DNA Ligase IV (Lig4), Xrcc2, Brca2) in neural development and medulloblastoma formation.
• To identify key genetic alterations and tumor suppressor genes involved in medulloblastoma development following DSBR pathway inactivation.

Main Methods:

• Inactivation of DSBR proteins (Lig4, Xrcc2, Brca2) and combined Lig4/Xrcc2 during neural development using Nestin-cre.
• Combined inactivation of repair factors with p53 loss.
• Genomic analysis including chromosomal analysis and sequence analysis of specific genes (Ptch1).

Main Results:

• Inactivation of DSBR factors combined with p53 loss rapidly induced medulloblastoma.
• Recurring chromosome 13 alterations involving Ptch1 and inactivating mutations in the remaining Ptch1 allele were observed in all tumors.
• Genomic amplification or up-regulation of N-Myc or cyclin D2, and selective deletion of chromosome 19 (containing Pten) in HR-disrupted medulloblastomas were noted.

Conclusions:

• Ptch1 acts as a critical tumor suppressor in cerebellar granule cells, with its inactivation being a key event in medulloblastoma genesis.
• Inactivation of DSBR pathways, particularly HR, contributes to medulloblastoma development through specific genomic alterations.
• The study reveals essential genomic events driving medulloblastoma formation following disruptions in DNA repair mechanisms.